Sellas Market Capitalization from 2010 to 2024
| SLS Stock | USD 1.13 0.04 3.42% |
Check Sellas Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sellas Life's main balance sheet or income statement drivers, such as Interest Expense of 806.9 K, Other Operating Expenses of 28.8 M or Research Development of 16.3 M, as well as many indicators such as Price To Sales Ratio of 60.05, Dividend Yield of 0.037 or Days Sales Outstanding of 78.69. Sellas financial statements analysis is a perfect complement when working with Sellas Life Valuation or Volatility modules.
Sellas | Market Capitalization |
Latest Sellas Life's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Sellas Life Sciences over the last few years. It is Sellas Life's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sellas Life's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 79.53 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Sellas Market Capitalization Regression Statistics
| Arithmetic Mean | 109,897,016 | |
| Geometric Mean | 58,352,973 | |
| Coefficient Of Variation | 92.62 | |
| Mean Deviation | 94,655,449 | |
| Median | 46,346,974 | |
| Standard Deviation | 101,784,742 | |
| Sample Variance | 10360.1T | |
| Range | 217.2M | |
| R-Value | (0.79) | |
| Mean Square Error | 4131.4T | |
| R-Squared | 0.63 | |
| Significance | 0.0004 | |
| Slope | (18,060,785) | |
| Total Sum of Squares | 145041.9T |
Sellas Market Capitalization History
About Sellas Life Financial Statements
Sellas Life shareholders use historical fundamental indicators, such as Market Capitalization, to determine how well the company is positioned to perform in the future. Although Sellas Life investors may analyze each financial statement separately, they are all interrelated. The changes in Sellas Life's assets and liabilities, for example, are also reflected in the revenues and expenses on on Sellas Life's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company was founded in 2012 and is headquartered in New York, New York. Sellas Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 11 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sellas Stock Analysis
When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.